Choose Your Language
Home  /  News

News

NIFTY™ is proud to be working with TATAA Biocentre in Gothenburg, Sweden.

--- 12 Oct 2014

NIFTY™ is pleased to welcome its new Swedish partner, TATAA Biocentre.

BGI Diagnostics Forms Partnership with ACIBADEM Hospital on Genetic Disease Testing

--- 1 Oct 2014

BGI Diagnostics and ACIBADEM Healthcare Group Genetic Diagnostic Center in cooperation with Genoks Company Molecular Biology, signed a Memorandum of Understanding (MoU) for jointly introducing the advanced genetic testing technologies to Turkey and improving Turkish reproductive healthcare. This partnership will foster the applications of genetic testing technologies in the areas of Monogenic disorders, personalized medical healthcare, birth defects that cause…

Istanbul Symposium—- Genomics in Reproductive Medicine was Successfully Conducted

--- 1 Oct 2014

November 17, 2013, Istanbul, Turkey–The Istanbul Symposium-Genomics in Reproductive Medicine, co-organized by BGI, Acibadem University, and Acibadem Labgen, was successfully held at Acibadem University, Istanbul. The conference provides an excellent opportunity for scientific leaders, genomic experts to share experiences on how to bring ideas from genomics research institutes into clinical applications. Included among the featured speakers were famous scientists, university…

NIFTY becomes First CFDA Approved Non-Invasive Prenatal Genetic Test

--- 1 Oct 2014

July 2, 2014 – BGI Diagnostics’ NIFTY™ test becomes First NIPT based on Next Generation Sequencing Technology to be Approved by the China Food and Drug Administration (CFDA). On June 30, 2014, the CFDA approved the registration of BGI’s BGISEQ-1000 and BGISEQ-100 sequencers, and its prenatal genetic testing kits for NIFTY™ (Non-Invasive Fetal Trisomy test). This is the first genetic…